Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9264 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9207 |
High Similarity |
NPD7472 |
Approved |
0.9182 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9157 |
High Similarity |
NPD7808 |
Phase 3 |
0.9146 |
High Similarity |
NPD7054 |
Approved |
0.9096 |
High Similarity |
NPD7251 |
Discontinued |
0.9091 |
High Similarity |
NPD7074 |
Phase 3 |
0.9036 |
High Similarity |
NPD6797 |
Phase 2 |
0.8706 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8598 |
High Similarity |
NPD7075 |
Discontinued |
0.8571 |
High Similarity |
NPD4380 |
Phase 2 |
0.8521 |
High Similarity |
NPD3818 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8324 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.828 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8253 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8229 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8229 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8228 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8193 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8111 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8081 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7975 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7925 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7879 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7865 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7785 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7749 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7742 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7688 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7683 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7679 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7669 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD5494 |
Approved |
0.764 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7592 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7698 |
Approved |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7472 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7461 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7461 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7449 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7449 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7435 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7435 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7418 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7412 |
Intermediate Similarity |
NPD920 |
Approved |
0.741 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD37 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7294 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7288 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7197 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7193 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD919 |
Approved |
0.7189 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7173 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6535 |
Approved |
0.717 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7091 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.6988 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD447 |
Suspended |
0.6982 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6982 |
Remote Similarity |
NPD2344 |
Approved |
0.697 |
Remote Similarity |
NPD7680 |
Approved |
0.6964 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD9545 |
Approved |
0.6943 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.694 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6932 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD943 |
Approved |
0.6927 |
Remote Similarity |
NPD4288 |
Approved |
0.6923 |
Remote Similarity |
NPD1247 |
Approved |
0.6914 |
Remote Similarity |
NPD3266 |
Approved |
0.6914 |
Remote Similarity |
NPD3267 |
Approved |
0.689 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD5710 |
Approved |
0.6885 |
Remote Similarity |
NPD5711 |
Approved |
0.6875 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6867 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6854 |
Remote Similarity |
NPD5890 |
Approved |
0.6854 |
Remote Similarity |
NPD5889 |
Approved |
0.6848 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6836
|
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |